Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
激动素作为一种安全且易出错的 SARS-CoV-2 抗病毒药物的临床前开发，能够减轻病毒引起的炎症
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-023-35928-z
Thiago Moreno L Souza #, Vagner D Pinho, Cristina F Setim, Carolina Q Sacramento, Rodrigo Marcon, Natalia Fintelman-Rodrigues, Otavio A Chaves, Melina Heller, Jairo R Temerozo, André C Ferreira, Mayara Mattos, Patrícia B Momo, Suelen S G Dias, João S M Gesto, Filipe Pereira-Dutra, João P B Viola, Ce
